In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Hiroki Teragawa
Speaker
Hiroki Teragawa
Hiroki Teragawa Hiroki Teragawa

JR Hiroshima Hospital, Hiroshima (Japan)

Specialities : Interventional Cardiology , Coronary Artery Disease Chronic, Nuclear Imaging

NAME Hiroki Teragawa, M.D., Ph.D., FACC, FACP, FAHA, FASNC, FESC, FSCAI, Business address and telephone: Department of Cardiovascular Medicine, JR Hiroshima Hospital, 3-1-36 Futabanosato, Higashi-ku, Hiroshima 732-0057, Japan Phone: +81-82-262-1171, Fax: +81-82-262-1499 E-mail: hiroteraga71@gmail.com PRESENT ACADEMIC RANK AND POSITION: The chief director of department of cardiovascular medicine and cardiac catheterization and interventions of JR Hiroshima Hospital My topic: coronary spasm, coronary circulation, PCI, HFpEF, cardiac amyloidosis, endothelial function

8 presentations from this speaker

Clinical characteristics of an intracoronary erosion and thrombus in patients with vasospastic angina

Event : ESC Congress 2019

  • Session : Coronary Artery Disease (Chronic)
  • Speaker : H Teragawa (Hiroshima,JP)

Can intracoronary pressure measured with a pressure wire predict spasm provocation?

Event : ESC Congress 2016

  • Session : Multi-modality imaging
  • Speaker : H Teragawa (Hiroshima,JP)

Prolonged chest symptoms in patients with vasospastic angina: what does this mean?

Event : ESC Congress 2015

  • Session : Angina pectoris stable V
  • Speaker : H Teragawa (Hiroshima,JP)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are